LLY$1,417.543.19%43.84
After Hours: 1,414.51-3.03 -0.21%
Lilly Eli Co (LLY)
Date: 2026-10-30 16:00O: 1,428.83H: 1,449.68L: 1,408.36C: 1,417.54Vol: 5.031M
Lilly Eli Co stock is traded at $1,417.54, with a volume of 5,031,115. It is up +3.19% in the last 24 hours and up +22.51% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,373.70
Open:
$1,428.83
24h Volume:
5,031,115
Relative Volume:
1.85
Market Cap:
$1.26T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
51.03
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+11.31%
1M Performance:
+22.51%
6M Performance:
+51.67%
1Y Performance:
+67.86%
1-Day Range:
$1,408.36$1,449.68
1-Week Range:
$1,260.34$1,449.68
52-Week Range:
$812.25$1,449.68
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USACompare LLY vs JNJ, ABBV, MRK, NVS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LLY Lilly Eli Co | $1,417.54 | $1.26T | $72.25B | $25.28B | $10.37B | $27.78 |
 JNJ Johnson Johnson | $273.20 | $657.68B | $97.93B | $21.04B | $17.80B | $8.63 |
 ABBV Abbvie Inc | $294.89 | $521.11B | $62.82B | $3.60B | $19.98B | $2.03 |
 MRK Merck Co Inc | $149.52 | $368.89B | $65.51B | $8.93B | $14.12B | $3.55 |
 NVS Novartis Ag Adr | $160.79 | $303.67B | $54.66B | $13.58B | $16.05B | $7.02 |
Lilly Eli Co Stock (LLY) Upgrades & Downgrades
Lilly Eli Co Stock (LLY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lilly Eli Co Stock (LLY) Insider Trading
- LILLY ENDOWMENT, INC.Oct 15 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $1,208.74
- #Shares
- 305,000
- Value ($)
- 368,665,700
- #Shares Total
- 0
- LILLY ENDOWMENT, INC.Oct 07 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $1,157.49
- #Shares
- 300,000
- Value ($)
- 347,247,000
- #Shares Total
- 0
- Jonsson PatrikAug 17 '26EVP & President, LLY Int'l
- Transaction
- Sale
- Cost
- $1,175.10
- #Shares
- 6,500
- Value ($)
- 7,638,150
- #Shares Total
- 54,147
- Patrik JonssonAug 17 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1,175.10
- #Shares
- 6,500
- Value ($)
- 7,638,150
- #Shares Total
- 0
- Zakrowski Donald AAug 10 '26SVP, Finance, & CAO
- Transaction
- Sale
- Cost
- $1,185.01
- #Shares
- 2,000
- Value ($)
- 2,370,020
- #Shares Total
- 1,526
- DONALD ZAKROWSKIAug 10 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1,185.71
- #Shares
- 2,000
- Value ($)
- 2,371,420
- #Shares Total
- 0
- Hakim AnatAug 07 '26Officer
- Transaction
- Proposed Sale
- Cost
- $1,190.00
- #Shares
- 10,000
- Value ($)
- 11,900,000
- #Shares Total
- 0
- Hakim AnatAug 07 '26EVP, GC & Secretary
- Transaction
- Sale
- Cost
- $1,190.00
- #Shares
- 5,000
- Value ($)
- 5,950,000
- #Shares Total
- 11,875
- Seymour MelissaAug 01 '26EVP, Global Quality
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 981
- Value ($)
- 0
- #Shares Total
- 1,506
- LILLY ENDOWMENT, INC.Jul 07 '26Shareholder
- Transaction
- Proposed Sale
- Cost
- $1,200.06
- #Shares
- 310,000
- Value ($)
- 372,018,600
- #Shares Total
- 0
